1. Epithelial NF-[kappa]B activation promotes urethane-induced lung carcinogenesis
- Author
-
Stathopoulos, Georgios T., Sherrill, Taylor P., Cheng, Dong-Sheng, Scoggins, Robert M., Han, Wei, Polosukhin, Vasiliy V., Connelly, Linda, Yull, Fiona E., Fingleton, Barbara, and Blackwell, Timothy S.
- Subjects
DNA binding proteins -- Health aspects ,DNA binding proteins -- Physiological aspects ,Lung tumors -- Risk factors ,Lung tumors -- Development and progression ,Epithelium -- Chemical properties ,Urethanes -- Physiological aspects ,Urethanes -- Health aspects ,Science and technology - Abstract
Chronic inflammation is linked to carcinogenesis in several organ systems. In the lungs, NF-[kappa]B, a central effector of inflammatory responses, is frequently activated in non-small-cell lung cancer, but its role in tumor promotion has not been studied. Several lines of evidence indicate that ethyl carbamate (urethane)-induced lung tumor formation, a prototypical mouse model of multistage lung carcinogenesis, is potentiated by inflammation. We found that mouse strains susceptible to lung tumor formation (FVB, BALB/c) exhibited early NF-[kappa]B activation and inflammation in the lungs after urethane treatment. However, a resistant strain (C57B6) failed to activate NF-[kappa]B or induce lung inflammation. In FVB mice, we identified urethane-induced NF-[kappa]B activation in airway epithelium, as well as type II alveolar epithelial cells and macrophages. Using an inducible transgenic mouse model (FVB strain) to express a dominant inhibitor of NF-[kappa]B specifically in airway epithelial cells, we found that urethane-induced lung inflammation was blocked and tumor formation was reduced by >50%. Selective NF-[kappa]B inhibition resulted in increased apoptosis of airway epithelial cells at 2 weeks after urethane treatment in association with a marked reduction of Bcl-2 expression. These studies indicate that NF-[kappa] apoptosis | cancer | inflammation | airway | adenocarcinoma
- Published
- 2007